ARTICLE | Clinical News
CNTX-4975: Ph IIb TRIUMPH data
December 15, 2016 10:26 PM UTC
Top-line data from the 24-week, double-blind, U.S. Phase IIb TRIUMPH trial in 175 patients with chronic, moderate to severe OA knee pain showed that a single injection into the knee of 0.5 and 1 mg CN...
BCIQ Company Profiles
BCIQ Target Profiles